Patents by Inventor Miquel David FERRER REYNÉS

Miquel David FERRER REYNÉS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INOSITOL PHOSPHATE COMPOUNDS FOR USE IN INCREASING TISSULAR PERFUSION
    Publication number: 20230248749
    Abstract: The present invention relates to inositol phosphates, analogs, derivatives and pharmaceutically acceptable salts thereof, for use in increasing tissular perfusion and/or oxygenation in a subject in need thereof, in particular peripheral arterial disease. The present invention also relates to pharmaceutical compositions comprising said inositol phosphates, analogs, derivatives and pharmaceutically acceptable salts thereof, and their use in increasing tissular perfusion and/or oxygenation and for treating and preventing peripheral arterial disease.
    Type: Application
    Filed: April 11, 2023
    Publication date: August 10, 2023
    Applicant: SANIFIT THERAPEUTICS, S.A.
    Inventors: Mohamad Firas BASSISSI, Carolina SALCEDO ROCA, Joan PERELLÓ BESTARD, Miquel David FERRER REYNÉS, María Del Mar PÉREZ FERRER
  • INOSITOL PHOSPHATE COMPOUNDS FOR USE IN TREATING, INHIBITING THE PROGRESSION, OR PREVENTING CARDIOVASCULA CALCIFICATION
    Publication number: 20220339171
    Abstract: The present invention relates to compounds, pharmaceutical compositions, combined preparations, and dosage regimens for treating, inhibiting the progression, and preventing cardiovascular calcification, and in particular, coronary calcification, aortic artery calcification, and aortic valve calcification comprising inositol phosphates. In a particular aspect the disclosure provides a dosage regimen for treating, inhibiting the progression, or preventing cardiovascular calcification comprising the administration of about 200 mg to about 700 mg of myo-inositol hexaphosphate per administration.
    Type: Application
    Filed: March 17, 2022
    Publication date: October 27, 2022
    Applicant: SANIFIT THERAPEUTICS, S.A.
    Inventors: Joan PERELLÓ BESTARD, Carolina SALCEDO ROCA, Miquel David FERRER REYNÉS
  • INOSITOL PHOSPHATE COMPOUNDS FOR USE IN INCREASING TISSULAR PERFUSION
    Publication number: 20220000889
    Abstract: The present invention relates to inositol phosphates, analogs, derivatives and pharmaceutically acceptable salts thereof, for use in increasing tissular perfusion and/or oxygenation in a subject in need thereof, in particular peripheral arterial disease. The present invention also relates to pharmaceutical compositions comprising said inositol phosphates, analogs, derivatives and pharmaceutically acceptable salts thereof, and their use in increasing tissular perfusion and/or oxygenation and for treating and preventing peripheral arterial disease.
    Type: Application
    Filed: July 20, 2021
    Publication date: January 6, 2022
    Applicant: SANIFIT THERAPEUTICS, S.A.
    Inventors: Mohamad Firas BASSISSI, Carolina SALCEDO ROCA, Joan PERELLÓ BESTARD, Miquel David FERRER REYNÉS, María Del Mar PÉREZ FERRER